R 28935 and prazosin: effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure.
D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D004146:Dioxanes / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011224:Prazosin / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D012018:Reflex / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D013116:Spinal Cord / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D004146:Dioxanes; D011799:Quinazolines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine; D011224:Prazosin